Piperazine compounds
US7465733B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2006 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Sep 19, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I):wherein: Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.